Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in Oviedo – page 12

315 clinical trials in Oviedo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Oviedo at a glance
315
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

315 trials in Oviedo

Open in trial search

Clear cell renal cell carcinoma

Not yet recruiting

A study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Vall D Hebron Institute Of Oncology

Hepatocellular carcinoma

Not yet recruiting

A study to evaluate the safety and effectiveness of PF-08634404 and ipilimumab in adults with advanced or spreading liver cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Pfizer Inc.

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Idiopathic pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Pancreatic carcinoma metastatic+1

Not yet recruiting

A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Dry eye

Not yet recruiting

Study on the Use of PRGF Eye Drops for Treating Dry Eye Disease in Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Hypromellose
  • Sponsor:Biotechnology Institute I Mas D S.L.

Colorectal cancer

Not yet recruiting

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive

Acute leukaemia+2

Not yet recruiting

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Cytomegalovirus infection

Not yet recruiting

Study on Preventing Cytomegalovirus Infection in Stem Cell Transplant Patients Using Cytolytic T Lymphocytes

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Instituto De Investigacion Marques De Valdecilla

Peripheral arterial occlusive disease

Not yet recruiting

Study on Bone Marrow Cells and Saline for Treating Severe Limb Ischemia in Patients at High Risk of Amputation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Dry eye

Not yet recruiting

Study on the Use of PRGF and Hypromellose Eye Drops for Treating Dry Eye Disease in Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Hypromellose
  • Sponsor:Biotechnology Institute I Mas D S.L.

Gastrooesophageal cancer

Not yet recruiting

Study of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Oviedo

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on gastric cancer, bladder cancer, and colorectal cancer treatments, evaluating novel combination therapies and targeted approaches.

  • Advanced pancreatic adenocarcinoma treatments
  • HER2-positive gastric cancer therapies
  • Non-muscle invasive bladder cancer interventions

Studies are investigating both immunotherapy combinations and targeted molecular treatments for various cancer types.

02 Respiratory Medicine

Research centered on treating Acute Respiratory Distress Syndrome and preventing severe respiratory infections in vulnerable populations.

  • RSV prevention in high-risk infants
  • ARDS treatment optimization
  • Advanced lung cancer therapies

Trials are evaluating both therapeutic and preventive approaches for respiratory conditions.

03 Hematology Studies

Comprehensive research on blood disorders, including chronic lymphocytic leukemia and acute myeloid leukemia, testing novel treatment combinations.

  • Leukemia treatment optimization
  • Novel therapeutic combinations
  • Targeted therapy approaches

Focus on improving outcomes through personalized treatment strategies and innovative drug combinations.

Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.